Revenues:
Product sales $74,476 $66,322 $213,524 $192,029
Contract
manufacturing
sales 3,370 4,036 11,269 11,439
Total revenues 77,846 70,358 224,793 203,468
Cost of revenues:
Cost of product
sales, including
idle capacity
costs 44,217 41,009 133,003 117,975
Cost of contract
manufacturing
sales 3,681 3,943 11,296 10,759
Total cost of
revenues 47,898 44,952 144,299 128,734
Gross margin 29,948 25,406 80,494 74,734
Operating expenses:
Research and
development 6,802 6,231 19,229 17,969
Selling, general
and administrative 12,939 11,328 36,526 31,465
Restructuring
charge 146 -- 747 --
Other operating
expenses 156 207 1,252 683
Total operating
expenses 20,043 17,766 57,754 50,117
Income from
operations 9,905 7,640 22,740 24,617
Interest and other,
net (288) (372) (1,162) (1,253)
Income before income
tax provision 9,617 7,268 21,578 23,364
Income tax
provision 3,491 2,653 7,833 8,528
Net income $6,126 $4,615 $13,745 $14,836
Basic earnings
per share $ 0.19 $0.14 $0.43 $0.46
Diluted earnings
per share $0.19 $0.14 $0.42 $0.46
'/>"/>| SOURCE Martek Biosciences Corporation Copyright©2007 PR Newswire. All rights reserved |